TY - JOUR T1 - A blood atlas of COVID-19 defines hallmarks of disease severity and specificity JF - medRxiv DO - 10.1101/2021.05.11.21256877 SP - 2021.05.11.21256877 AU - COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium AU - David J Ahern AU - Zhichao Ai AU - Mark Ainsworth AU - Chris Allan AU - Alice Allcock AU - Azim Ansari AU - Carolina V Arancibia-Carcamo AU - Dominik Aschenbrenner AU - Moustafa Attar AU - J. Kenneth Baillie AU - Eleanor Barnes AU - Rachael Bashford-Rogers AU - Archana Bashyal AU - Sally Beer AU - Georgina Berridge AU - Amy Beveridge AU - Sagida Bibi AU - Tihana Bicanic AU - Luke Blackwell AU - Paul Bowness AU - Andrew Brent AU - Andrew Brown AU - John Broxholme AU - David Buck AU - Katie L Burnham AU - Helen Byrne AU - Susana Camara AU - Ivan Candido Ferreira AU - Philip Charles AU - Wentao Chen AU - Yi-Ling Chen AU - Amanda Chong AU - Elizabeth Clutterbuck AU - Mark Coles AU - Christopher P Conlon AU - Richard Cornall AU - Adam P Cribbs AU - Fabiola Curion AU - Emma E Davenport AU - Neil Davidson AU - Simon Davis AU - Calliope Dendrou AU - Julie Dequaire AU - Lea Dib AU - James Docker AU - Christina Dold AU - Tao Dong AU - Damien Downes AU - Alexander Drakesmith AU - Susanna J Dunachie AU - David A Duncan AU - Chris Eijsbouts AU - Robert Esnouf AU - Alexis Espinosa AU - Rachel Etherington AU - Benjamin Fairfax AU - Rory Fairhead AU - Hai Fang AU - Shayan Fassih AU - Sally Felle AU - Maria Fernandez Mendoza AU - Ricardo Ferreira AU - Roman Fischer AU - Thomas Foord AU - Aden Forrow AU - John Frater AU - Anastasia Fries AU - Veronica Gallardo Sanchez AU - Lucy Garner AU - Clementine Geeves AU - Dominique Georgiou AU - Leila Godfrey AU - Tanya Golubchik AU - Maria Gomez Vazquez AU - Angie Green AU - Hong Harper AU - Heather A Harrington AU - Raphael Heilig AU - Svenja Hester AU - Jennifer Hill AU - Charles Hinds AU - Clare Hird AU - Ling-Pei Ho AU - Renee Hoekzema AU - Benjamin Hollis AU - Jim Hughes AU - Paula Hutton AU - Matthew Jackson AU - Ashwin Jainarayanan AU - Anna James-Bott AU - Kathrin Jansen AU - Katie Jeffery AU - Elizabeth Jones AU - Luke Jostins AU - Georgina Kerr AU - David Kim AU - Paul Klenerman AU - Julian C Knight AU - Vinod Kumar AU - Piyush Kumar Sharma AU - Prathiba Kurupati AU - Andrew Kwok AU - Angela Lee AU - Aline Linder AU - Teresa Lockett AU - Lorne Lonie AU - Maria Lopopolo AU - Martyna Lukoseviciute AU - Jian Luo AU - Spyridoula Marinou AU - Brian Marsden AU - Jose Martinez AU - Philippa Matthews AU - Michalina Mazurczyk AU - Simon McGowan AU - Stuart McKechnie AU - Adam Mead AU - Alexander J Mentzer AU - Yuxin Mi AU - Claudia Monaco AU - Ruddy Montadon AU - Giorgio Napolitani AU - Isar Nassiri AU - Alex Novak AU - Darragh O'Brien AU - Daniel O'Connor AU - Denise O'Donnell AU - Graham Ogg AU - Lauren Overend AU - Inhye Park AU - Ian Pavord AU - Yanchun Peng AU - Frank Penkava AU - Mariana Pereira Pinho AU - Elena Perez AU - Andrew J Pollard AU - Fiona Powrie AU - Bethan Psaila AU - T. Phuong Quan AU - Emmanouela Repapi AU - Santiago Revale AU - Laura Silva-Reyes AU - Jean-Baptiste Richard AU - Charlotte Rich-Griffin AU - Thomas Ritter AU - Christine S Rollier AU - Matthew Rowland AU - Fabian Ruehle AU - Mariolina Salio AU - Stephen N Sansom AU - Alberto Santos Delgado AU - Tatjana Sauka-Spengler AU - Ron Schwessinger AU - Giuseppe Scozzafava AU - Gavin Screaton AU - Anna Seigal AU - Malcolm G Semple AU - Martin Sergeant AU - Christina Simoglou Karali AU - David Sims AU - Donal Skelly AU - Hubert Slawinski AU - Alberto Sobrinodiaz AU - Nikolaos Sousos AU - Lizzie Stafford AU - Lisa Stockdale AU - Marie Strickland AU - Otto Sumray AU - Bo Sun AU - Chelsea Taylor AU - Stephen Taylor AU - Adan Taylor AU - Supat Thongjuea AU - Hannah Thraves AU - John A Todd AU - Adriana Tomic AU - Orion Tong AU - Amy Trebes AU - Dominik Trzupek AU - Felicia A Tucci AU - Lance Turtle AU - Irina Udalova AU - Holm Uhlig AU - Erinke van Grinsven AU - Iolanda Vendrell AU - Marije Verheul AU - Alexandru Voda AU - Guanlin Wang AU - Lihui Wang AU - Dapeng Wang AU - Peter Watkinson AU - Robert Watson AU - Michael Weinberger AU - Justin Whalley AU - Lorna Witty AU - Katherine Wray AU - Luzheng Xue AU - Hing Yuen Yeung AU - Zixi Yin AU - Rebecca K Young AU - Jonathan Youngs AU - Ping Zhang AU - Yasemin-Xiomara Zurke Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/11/2021.05.11.21256877.abstract N2 - Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete understanding of potentially druggable immune mediators of disease. To advance this, we present a comprehensive multi-omic blood atlas in patients with varying COVID-19 severity and compare with influenza, sepsis and healthy volunteers. We identify immune signatures and correlates of host response. Hallmarks of disease severity revealed cells, their inflammatory mediators and networks as potential therapeutic targets, including progenitor cells and specific myeloid and lymphocyte subsets, features of the immune repertoire, acute phase response, metabolism and coagulation. Persisting immune activation involving AP-1/p38MAPK was a specific feature of COVID-19. The plasma proteome enabled sub-phenotyping into patient clusters, predictive of severity and outcome. Tensor and matrix decomposition of the overall dataset revealed feature groupings linked with disease severity and specificity. Our systems-based integrative approach and blood atlas will inform future drug development, clinical trial design and personalised medicine approaches for COVID-19.Competing Interest StatementRBR is a cofounder and consultant of Alchemab Therapeutics Ltd. RC is Founder of MIROBio. JH is Director and shareholder of Nucleome Therapeutics. GS sits on GSK Vaccines SAB.Funding StatementThe research was supported by the University of Oxford COVID-19 Research Response Fund, Wellcome Trust Core Award Grant Number 203141/Z/16/Z and the NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:South Central Oxford C Research Ethics Committee (REC) in England (Sepsis Immunomics REC reference 19/SC/0296; ISARIC WHO Clinical Characterisation Protocol for Severe Emerging Infections REC reference 13/SC/0149)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from our study can be explored interactively through a web portal: https://mlv.combat.ox.ac.uk/ https://mlv.combat.ox.ac.uk/ ER -